http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-102190674-B1
Outgoing Links
Predicate | Object |
---|---|
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K51-0474 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D275-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D255-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K51-0438 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D255-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D275-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K51-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
filingDate | 2018-11-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2020-12-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2020-12-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | KR-102190674-B1 |
titleOfInvention | Sodium saccharin conjugated ligand, derivatives thereof and process for the preparetion thereof |
abstract | The present invention provides a compound having a selective target for hypoxic tumors by providing a ligand compound-bound saccharin sodium, a derivative thereof, and a method for preparing the same. Specifically, it can be applied to a contrast medium for tumor diagnosis by providing a compound obtained by binding a ligand to sodium saccharin or a derivative thereof. |
priorityDate | 2017-12-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 42.